Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

AMRI Global

Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services. The company provides scientific services, products and technologies that improve quality of life while delivering excellence, value and maximum return.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group logo

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Market access, Regulatory affairs, Research and development

Company Details

AMRI Global
Mostyn Road, Holywell, Flintshire, Wales, CH8 9DN, United Kingdom
+44 (0)1352 717100
Contact AMRI Global
Website

 Latest Content from PMHub 

UK vs US: what makes a successful immunisation programme?

White Papers and Resources | October 30, 2019 | Blue Latitude Health

Emily Macdonald calls on her experience as a public health nurse specialising in the prevention of infectious disease in both the US and UK, to explore the differences between immunisation...

Bedrock are in the Top 3

Press Releases | October 29, 2019 | Resonant Group

Bedrock named No. 3 Young Agency by PMLive

Are we ready for an Alzheimer’s disease modifying treatment

White Papers and Resources | October 29, 2019 | Blue Latitude Health

Millions of people across the globe have Alzheimer’s disease and currently, there is no cure. But if a new therapy entered the market today, would healthcare systems be ready for...

Millennial Physicians And Digital Health Services

Videos and Podcasts | October 23, 2019 | Wilmington Healthcare

Can Millennial Physicians and Digital Health Services Fix the Patient-Doctor Relationship?

Tapping the potential of rare diseases: A journey into uncharted territory

White Papers and Resources | October 23, 2019 | Porterhouse Medical Group

Delivering effective treatment for rare diseases remains a major unmet medical need. Fortunately, scientific advances are rapidly enhancing our ability to identify, diagnose and ultimately treat these conditions. Coupled with...

Spotlight interview: 15 minutes on PR in pharma

White Papers and Resources | October 17, 2019 | OPEN Health

Vicky Bramham, Managing Director, OPEN Health takes 15 minutes to answer some key questions on PR discipline.

eyeforpharma Marketing and Customer Innovation Europe

White Papers and Resources | October 17, 2019 | Four Agency Worldwide

By Richard Springham

Wilmington Healthcare appoints new consultants

Press Releases | October 17, 2019 | Wilmington Healthcare

Healthcare intelligence provider Wilmington Healthcare, which incorporates HSJ, Interactive Medica and OnMedica, has expanded its team with the appointment of two new senior consultants - Roger Tomlins and Sarah Shield.

What is changing in cardiovascular disease care?

White Papers and Resources | October 16, 2019 | Wilmington Healthcare

Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma

PANDAS/PANS Awareness: A parent’s story

White Papers and Resources | October 15, 2019 | Porterhouse Medical Group

To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS